Metropolis Healthcare Q1 net profit surge 31% YoY to ₹38 crore; check earnings update

The company’s consolidated net profit grew over 31% YoY to ₹38.11 crore in Q1FY25 compared to ₹28.98 crore in Q1FY24. In Q1FY25, the company’s PAT grew over 4% quarter-on-quarter from ₹36.52 crore in the March quarter.

The company’s PAT margin increased by 170 basis points to 12.2% in Q1FY25 compared to 10.5% in the corresponding quarter of the preceding fiscal.

The healthcare company’s consolidated revenue from operations grew 38% to ₹313.35 crore in the June quarter of FY25 compared to ₹227 crore in the June quarter of FY24. However, the company’s revenue from operations declined more than 5% QoQ from ₹331 crore in the March quarter of FY24.

Its earnings before interest, taxes, depreciation, and amortisation (EBITDA) increased over 21% to ₹78.2 crore in Q1FY25 compared to ₹64.5 crore in Q1FY24. EBITDA Margins for the June quarter of FY25 grew 170 basis points to 25% against 23.3% in the corresponding quarter of the preceding fiscal.

In Q1FY25, the diagnostics company posted a 7% growth in patient volumes, and test volume increased 10%. The company’s revenue per patient grew 6% in the June quarter.

Metropolis Healthcare is present in 22 states, 3 Union Territories, and over 650 towns. The diagnostics company offers more than 4,000 tests.

Metropolis Healthcare shares closed at ₹2,036 apiece, down 1.07%, on the NSE amid profit booking.